Several prognostic factors such as age at diagnosis, DNA index (ploidy), MYCN amplification, and tumor stage are used to stratify NB into very low-risk, low-risk, intermediate-risk, and high-risk (HR) groups [3]. The gene discussed is MYCN; the disease is neuroblastoma.